VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC

医学 肝细胞癌 危险系数 接收机工作特性 高强度 放射科 逻辑回归 磁共振成像 优势比 置信区间 内科学 核医学
作者
Hanyu Jiang,Hong Wei,Ting Yang,Yun Qin,Yuanan Wu,Weixia Chen,Yujun Shi,Maxime Ronot,Mustafa R. Bashir,Bin Song
出处
期刊:Radiology [Radiological Society of North America]
卷期号:307 (2) 被引量:28
标识
DOI:10.1148/radiol.221835
摘要

Background Peritumoral hepatobiliary phase (HBP) hypointensity is an established prognostic imaging feature in hepatocellular carcinoma (HCC), often associated with microvascular invasion (MVI). Similar prognostic features are needed for non-HBP MRI. Purpose To propose a non-hepatobiliary-specific MRI tool with similar prognostic value to peritumoral HBP hypointensity. Materials and Methods From December 2011 to November 2021, consecutive patients with HCC who underwent preoperative contrast-enhanced MRI were retrospectively enrolled and followed up until recurrence. All MRI scans were reviewed by two blinded radiologists with 7 and 10 years of experiences with liver MRI. A scoring system based on non-hepatobiliary-specific features that highly correlated with peritumoral HBP hypointensity was identified in a stratified sampling-derived training set of the gadoxetate disodium (EOB) group by means of multivariable logistic regression, and its values to predict MVI and recurrence-free survival (RFS) were assessed. Results There were 660 patients (551 men; median age, 53 years; IQR, 45-61 years) enrolled. Peritumoral portal venous phase hypoenhancement (odds ratio [OR] = 8.8), incomplete "capsule" (OR = 3.3), corona enhancement (OR, 2.6), and peritumoral mild-moderate T2 hyperintensity (OR, 2.2) (all P < .001) were associated with peritumoral HBP hypointensity and constituted the "VICT2 trait" (test set area under the receiver operating characteristic curve = 0.84; 95% CI: 0.78, 0.90). For the EOB group, both peritumoral HBP hypointensity (OR for MVI = 2.5, P = .02; hazard ratio for RFS = 2.5, P < .001) and the VICT2 trait (OR for MVI = 5.1, P < .001; hazard ratio for RFS = 2.3, P < .001) were associated with MVI and RFS, despite a higher specificity of the VICT2 trait for MVI (89% vs 80%, P = .01). These values of the VICT2 trait were confirmed in the extracellular contrast agent group (OR for MVI = 4.0; hazard ratio for RFS = 1.7; both P < .001). Conclusion Based on four non-hepatobiliary-specific MRI features, the VICT2 trait was comparable to peritumoral hepatobiliary phase hypointensity in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinoma. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Harmath in this issue.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
外向的问儿完成签到 ,获得积分10
1秒前
1秒前
小白发布了新的文献求助10
1秒前
1秒前
sunish发布了新的文献求助100
1秒前
蓦然发布了新的文献求助10
2秒前
2秒前
3秒前
悦耳绮玉发布了新的文献求助10
3秒前
沙司利益发布了新的文献求助10
3秒前
superchen发布了新的文献求助10
3秒前
3秒前
FashionBoy的应助被Ao采纳,获得10
4秒前
4秒前
4秒前
不加香菜完成签到 ,获得积分10
4秒前
phillip521125发布了新的文献求助10
4秒前
汉堡包的应助被huhdcid采纳,获得10
5秒前
5秒前
abocide发布了新的文献求助30
5秒前
FashionBoy的应助被困了采纳,获得10
5秒前
zzr完成签到,获得积分10
5秒前
6秒前
稳重的菠萝完成签到,获得积分20
6秒前
7秒前
xu发布了新的文献求助10
7秒前
涵涵完成签到 ,获得积分20
8秒前
xing_xing的应助被xiaolizi采纳,获得30
8秒前
9秒前
9秒前
10秒前
Hello的应助被刘的花采纳,获得10
10秒前
龙龙冲发布了新的文献求助10
11秒前
cxt发布了新的文献求助10
11秒前
YZL完成签到,获得积分10
11秒前
初景的应助被sunish采纳,获得20
12秒前
12秒前
科研通AI6.2的应助被yy采纳,获得10
12秒前
黎深深发布了新的文献求助30
12秒前
Cathy完成签到 ,获得积分10
12秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Organizational Behavior 510
A Silent Apostrophe:The Fayum Portraits 350
Sing with Understanding: Introduction to Theology in Christian Congregational Song, 3rd ed 330
Auslegung und Untersuchung einer invers ausgelegten Beschaufelung eines einstufigen Axialverdichters mit Vorleitrad (German) 300
AI-Contracting 300
四川大学学位论文.郭瑞昂. 基于高压热扩散的n型磷掺杂金刚石半导体制备研究 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7839662
求助须知:如何正确求助?哪些是违规求助? 9361574
关于积分的说明 20621588
捐赠科研通 7434031
什么是DOI,文献DOI怎么找? 3339365
关于科研通互助平台的介绍 2483750
邀请新用户注册赠送积分活动 2360950